Enteral Nutrition in the Netherlands
SKU:
$1,990.00
$1,990.00
per item
Around 40 percent of all hospital patients worldwide are malnourished. In the Netherlands, around 2.1 mil. Patients well 25% malnourished, which thus have a BMI of less than 18.5 kg / m² - tendency is increasing. The Dutch market for enteral nutrition is a growth market, which is decisively influenced by the possibility of prescribing and reimbursing food.
The Qnidos Deutsche Health Intelligence study "Enteral Nutrition in the Netherlands" provides managers of manufacturers and service providers with a comprehensive insight into current and future market events. The focus of the market investigation is on the detailed presentation of the situation of enteral nutrition in the inpatient and outpatient sector. The market shares of selected manufacturers and service providers are also presented.
In addition to a detailed growth forecast for the next three years, the study answers the following questions on enteral nutrition:
How does the Dutch health insurance system work?
How does the reimbursement market for enteral nutrition work?
How is the market volume distributed among the individual segments (drinking, probe food, medical technology)?
How are the inpatient and outpatient markets developing?
What development have the patient numbers in the inpatient and outpatient market?
The Qnidos Deutsche Health Intelligence study "Enteral Nutrition in the Netherlands" provides managers of manufacturers and service providers with a comprehensive insight into current and future market events. The focus of the market investigation is on the detailed presentation of the situation of enteral nutrition in the inpatient and outpatient sector. The market shares of selected manufacturers and service providers are also presented.
In addition to a detailed growth forecast for the next three years, the study answers the following questions on enteral nutrition:
How does the Dutch health insurance system work?
How does the reimbursement market for enteral nutrition work?
How is the market volume distributed among the individual segments (drinking, probe food, medical technology)?
How are the inpatient and outpatient markets developing?
What development have the patient numbers in the inpatient and outpatient market?
